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Abstract—Alterations in serotonin (5-HT) neurochemistry
have been implicated in the aetiology of all major neuro-
psychiatric disorders, ranging from schizophrenia to
mood and anxiety-spectrum disorders. This review will
focus on the multifaceted implications of 5-HT-ergic dys-
functions in the pathophysiology of aggressive and sui-
cidal behaviours. After a brief overview of the
anatomical distribution of the 5-HT-ergic system in the
key brain areas that govern aggression and suicidal
behaviours, the implication of 5-HT markers (5-HT recep-
tors, transporter as well as synthetic and metabolic
enzymes) in these conditions is discussed. In this regard,
particular emphasis is placed on the integration of phar-
macological and genetic evidence from animal studies
with the ﬁndings of human experimental and genetic
association studies. Traditional views postulated an
inverse relationship between 5-HT and aggression and
suicidal behaviours; however, ample evidence has shown
that this perspective may be overly simplistic, and that
such pathological manifestations may reﬂect alterations
in 5-HT homoeostasis due to the interaction of genetic,
environmental and gender-related factors, particularly dur-
ing early critical developmental stages. The development
of animal models that may capture the complexity of
such interactions promises to aﬀord a powerful tool to
elucidate the pathophysiology of impulsive aggression
and suicidability, and identify new eﬀective therapies for
these conditions.  2013 IBRO. Published by Elsevier
Ltd. All rights reserved.
Key words: impulsive-aggressive behaviours, suicide, 5-HT
receptors, tryptophan hydroxylase, 5-HT transporter, mono-
amine oxidase A.
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INTRODUCTION: CHALLENGING THE 5-HT
DEFICIENCY HYPOTHESIS IN SUICIDAL
BEHAVIOUR
The deﬁnition of suicidal behaviours encompasses a
broad constellation of heterogeneous entities, ranging
from suicidal thoughts and death wishes to attempted
and completed suicide. The great diversity of suicidal
behaviours reﬂects their comorbidity with diﬀerent
psychiatric disorders, including aﬀective disorders,
psychoses, alcohol abuse and/or dependence, etc. In
particular, numerous studies have shown a very robust
association between multiple aspects of suicidal conduct
and aggression. In keeping with this idea, multiple
studies have pointed to pathological aggression and
antisocial personality as major risk factors for suicide
(Conner et al., 2001; Gureje et al., 2011).
The bulk of evidence points to the existence of at least
two major subtypes of aggression, characterized by
distinct behavioural proﬁles and neural underpinnings:
proactive aggression, typically calculated and
instrumental to gaining rewards; and reactive
aggression, which is generally enacted impulsively as a
stress-coping response to potentially threatening
contingencies (Poulin and Boivin, 2000). Research has
shown that both subtypes of aggression may inﬂuence
suicidal conduct. Indeed, reactive aggression and
impulsive personality characteristics have been recently
highlighted as major risk factors for suicidal ideation and
behaviour (Pfeﬀer et al, 2000; Conner et al, 2003;
Dougherty et al, 2004; Hull-Blanks et al, 2004; Smith
et al, 2008). Although impulsive actions often result in
higher likelihood of self-inﬂicted painful and provocative
experiences, they are rarely conducive to attempted and
completed suicide, which typically require prior planning
(Baca-Garcia et al, 2005; Wyder and De Leo, 2007;
Smith et al, 2008; Witte et al, 2008). Conversely, while
proactive aggression has been often regarded as
unrelated to suicide, recent studies have shown that this
subtype is actually associated to suicide attempt in men,
but not women (Conner et al., 2009). Taken together,
these ﬁndings underscore the complex, multifaceted
relationship between aggressive manifestations and
suicidal behaviours.
The neurobiological link between aggression and
suicide is apparently contributed by imbalances in
serotonin (5-HT) neurotransmission. Findings from
preclinical and clinical studies have indicated that
dysregulations of 5-HT release, signalling and/or
turnover may be robust correlates of violent reactivity
(Virkkunen et al., 1995; Higley and Linnoila, 1997;
Stanley et al., 2000) and impulsive-aggressive
behaviours (IABs), which have been recently highlighted
as critical intermediate phenotypes for suicidal conduct
(Turecki, 2005; Zouk et al., 2007; Mann et al., 2009).
Notably, both reactive aggression and suicide are
aﬀected by multiple biological variables that inﬂuence
the regulation of 5-HT-ergic neurotransmission,
including psychosocial stress, traumatic experiences,
pathological personality traits, mental disorders, alcohol
abuse and nicotine addiction (Turecki, 2001; Gibb et al.,
2006; Nock et al., 2008; Mann et al., 2009; Pivac et al.,
2010). For several decades the link between 5-HT and
aggression was explained by a ‘‘5-HT deﬁciency
hypothesis’’, which posited a direct association of
reduced CSF concentrations of 5-HT and/or its
metabolite 5-hydroxyindoleacetic acid (5-HIAA) and
suicidal/aggressive behaviour. Accumulating evidence,
however, shows that this theory is inadequate to
account for the pleiotropic role of 5-HT in the modulation
of pathological aggression and suicidal behaviours; thus,
current views postulate that IABs may be the ﬁnal
outcome of diﬀerent homoeostatic imbalances of the 5-
HT system.
In the following section, we will brieﬂy describe the 5-
HT innervations of the forebrain regions involved in IABs
and suicidal behaviours, such as the prefrontal cortex
(PFC), amygdala and nucleus accumbens (NAc)
(Davidson et al., 2000) (Fig. 1). In addition, we will
overview the preclinical and clinical evidence on the
best-characterized 5-HT-ergic targets implicated in
violent and suicidal behaviours, including its receptors,
Fig. 1. Midsagittal view of the rat brainstem with serotonin-immunoreactive cell body groups. The ovals encompass the two major subdivisions of
the brain serotonergic system. Abbreviations: DRN, dorsal raphe nucleus; MRN, medial raphe nucleus; NRM; nucleus raphe magnus; NRO,
nucleus raphe obscurus. Cell groups B1 to B9 according to the terminology of Dahlstrom and Fuxe (1964). 5-HT innervations of the areas involved
in aggression and suicide are depicted.
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its key biosynthetic enzyme tryptophan hydroxylase
(TPH), its transporter (5-HTT) and the main catabolic
enzyme, monoamine oxidase (MAO) A (Fig. 2).
THE SEROTONERGIC SYSTEM IN
AGGRESSION AND SUICIDE
One of the oldest biologically active compounds, 5-HT is
found across all eukaryote kingdoms, including protists,
plants, fungi and animals. Given its ubiquitous presence
in the body, it is not surprising that 5-HT is involved in a
plethora of physiological and pathophysiological
processes (Jacobs and Azmitia, 1992). Based on the
distribution of 5-HT in the organism, its system can be
divided into a central and a peripheral subsystem
(Murphy et al., 2008a); the latter, which includes the
gastrointestinal (GI) tract, lung, heart, pancreatic tissue,
blood vessels and platelets (Thompson, 1971; Cirillo
et al., 2011), contains the greatest concentration (90%)
of 5-HT (up to 10 mg in humans). Conversely, only a
relatively small amount of 5-HT is found in the CNS.
The central 5-HT subsystem is one of the diﬀusively
organized projection systems of the mammalian brain
and it is topographically organized with respect to
anatomic and functional properties (Abrams et al.,
2004). The majority of the cell bodies of the 5-HT-ergic
neurons are located in the raphe´ nuclei, within the
reticular formation of the brainstem. Although the 5-HT-
ergic neurons are multipolar, their size and orientation
vary considerably across distinct locations; in fact, their
complex axonal systems innervate virtually all CNS
regions, although their distribution is particularly dense
in the cerebral cortex, limbic structures, basal ganglia,
many regions of the brainstem and the grey matter of
the spinal cord.
Dahlstrom and Fuxe (1964) clustered the 5-HT
neurons in the rat brainstem into nine nuclei, termed B1
to B9 (B1 being the most caudal one) (Fig. 1). In
addition, these midline clusters can be further
categorized into two major groups:
– the caudal or inferior group, localized in the medulla,
which contains three nuclei projecting essentially to
the grey matter of the spinal cord: the nucleus raphe
magnus (NRM, cell group B5), nucleus raphe obscurus
(NRO, cell groups B1-B2-B3), and nucleus raphe palli-
dus (NRP, cell group B4);
– the rostral or superior group, situated in the pons and
midbrain, which contains the dorsal raphe nucleus
(DRN, cell groups B6 and B7), estimated to contain
235,000 neurons in the human brain (Baker et al.,
1990) and the median raphe nucleus (MRN, cell group
B8) (Fig. 1). The main target regions of these 5-HT-
ergic projections are located in the forebrain and spinal
cord.
Serotonergic innervation and 5-HT receptors
distribution in PFC, amygdala and NAc
The ascending projections of 5-HT neurons are very
extensive, and their collateral branches innervate
numerous regions of the cerebral cortex, basal ganglia,
limbic system and diencephalon. Although all the axons
travel within the medial forebrain bundle in their initial
tracts, many of them extend from this structure,
following other ﬁbre pathways up to their target areas.
The 5-HT-ergic system in the PFC. The 5-HT
innervation of the cerebral cortex originates from the
midbrain DRN and MRN, and spreads to every allo- and
iso-cortical area, with variable ﬁbre density across the
diﬀerent layers. In primates, the 5-HT-ergic innervation
of the cortex is particularly dense in the granular cell
layers (layer IV) (Hillegaart, 1991; Van Bockstaele et al.,
1993). The rich 5-HT-ergic innervations the medial PFC
(mPFC) (as well as most of the frontal cortex) originate
almost exclusively in the DRN (Van Bockstaele et al.,
Fig. 2. The biosynthesis of serotonin. Tryptophan hydroxylase (TPH)
catalyses the ﬁrst and rate-limiting step in the synthesis of serotonin
(5-HT) using tetrahydrobiopterin and dioxygen as co-substrates and
producing water and dihydrobiopterin as byproducts. The second and
ﬁnal reaction in the biosynthesis of serotonin is catalysed by the
aromatic amino acid decarboxylase. Monoamine oxidase (MAO)
catalyses the oxidative deamination of 5-HT.
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1993). The orbitofrontal cortex (OFC) is also primarily
innervated by the DRN (Dringenberg and Vanderwolf,
1997), and contains an extremely dense plexus of ﬁne
axons featuring minute varicosities. Axonal tracing
studies show that DRN neurons project to the frontal
cortex following well-characterized rostro-caudal and
dorso-ventral topographic patterns (Waterhouse et al.,
1986). The MRN innervation consists of few thick,
beaded serotonergic axons with large spherical
varicosities (Wilson and Molliver, 1991). The distribution
of the 5-HT-ergic innervation varies according to the
types of cortex and the cytoarchitectonic regions; thus,
5-HTT density in agranular/dysgranular (caudal) OFC is
higher than that in granular (rostral) OFC, and there is a
medial-to-lateral decreasing gradient within the
agranular/dysgranular regions (Way et al., 2007). The
OFC and mPFC send direct projections down to the
raphe´ nuclei, providing a substrate for top-down control
over the 5-HT-ergic forebrain pathways.
The PFC features an abundant expression of several
5-HT receptor families. In particular, members of the 5-
HT1 receptor family such as 5-HT1A and 5-HT1B, are
localized both pre-synaptically (autoreceptors) on the
dendrites of 5-HT ﬁbres and post-synaptically
(heteroreceptors) on pyramidal cells and diﬀerent types
of interneurons (Azmitia et al., 1996; Santana et al.,
2004). Activation of post-synaptic 5-HT1A and 5-HT1B
receptors in the pyramidal cells of cortex produces
hyperpolarizing responses, while pre-synaptic 5-HT1
receptors, reduces the amplitude of electrically evoked
excitatory post-synaptic potentials (EPSPs), including
both N-methyl-D-aspartate (NMDA) and non-NMDA
glutamate receptors (Tanaka and North, 1993).
Conversely, in vivo treatment with a low dose of 5-HT1A
receptor agonist 8-OH-DPAT activates these receptors
on GABA-ergic interneurons, leading to an indirect
increase of the discharge rate of pyramidal neurons in
mPFC (Llado-Pelfort et al., 2012). 5-HT2A/2C receptors
are also densely distributed in the PFC; 5-HT2A are co-
expressed with 5-HT1A in pyramidal cells and both
parvalbumin (PV)- and calbindin (CB)-containing
interneurons (Santana et al., 2004). 5-HT2A receptors
activation induces depolarization of both cell types
(Aghajanian and Sanders-Bush, 2002).
Electrophysiologically, in layer V pyramidal cells,
synaptic events induced by 5-HT2A consist largely of
EPSPs although inhibitory post-synaptic potentials
(IPSPs) can be recorded due to GABA-ergic
interneurons activation (Aghajanian and Sanders-Bush,
2002). The 5-HT2C receptor is primarily expressed in the
deep layers of the rat mPFC by calcium-binding
proteins-positive GABA-ergic interneurons in rat
pyramidal cells (Liu et al., 2007), while its mRNA is
absent in pyramidal-shaped cells in both human and
monkey PFC (Pasqualetti et al., 1999). Activation of 5-
HT2C receptors induces neuronal depolarization (Di
Giovanni et al., 2008b, 2011). Thus, the pyramidal cell
inhibition seen by stimulation of the 5-HT2C receptor is
likely due to excitation of PV-positive interneurons in the
mPFC (Di Giovanni et al., 2011). The expression of 5-
HT2C receptors in the deep layers of the rat mPFC
(layers V–VI), suggests that the action of 5-HT2C
receptor may modulate the neuronal output in these
layers (Liu et al., 2007).
Several lines of evidence indicate that the other 5-HT
receptors are also expressed in the neocortex. In
particular, 5-HT3 receptors are mainly localized in the
superﬁcial layers of the cortex and are particularly
abundant in GABA-ergic interneurons (Tecott et al.,
1993; Morales and Bloom, 1997; Miquel et al., 2002;
Puig et al., 2004). With respect to the distribution of
other 5-HT receptors in the PFC, 5-HT4 are particularly
expressed in superﬁcial layers (Varna¨s et al., 2003) and
mostly in pyramidal neurons (Lambe et al., 2011);
conversely, 5-HT6 are relatively sparse (Marazziti et al.,
2012) and mostly localized in the interneurons (Lambe
et al., 2011). Finally, 5-HT7 receptors have also been
documented in the frontal pole of the neocortex of
rodents and humans (To et al., 1995; Gustafson et al.,
1996). The function of these receptors in the cortex is
still poorly understood.
The 5-HT-ergic system in the amygdala. In all species
studied to date, the amygdala features an exceptionally
rich 5-HT-ergic innervation, arising mainly from the DRN
(Smith and Porrino, 2008); virtually all neuropeptide Y
(NPY)-immunoreactive (ir) neurons receive peri-somatic
serotonergic innervations (Bonn et al., 2012). 5-HT1A
and 5-HT2A expression has been found in both
pyramidal cells and inhibitory interneurons (Aznar et al.,
2003; McDonald and Mascagni, 2007). 5-HT1B receptors
are also expressed in diﬀerent amygdaloid nuclei and
their expression increases in rats exposed to aggression
only in the basolateral amygdala (Suzuki et al., 2010).
The cellular expression of 5-HT2C receptors in pyramidal
neurons of the amygdala has not been studied yet, but
recent evidence shows that NPY mRNA-producing
interneurons co-express both 5-HT1A and 5-HT2C
mRNAs (Bonn et al., 2012). Although these anatomical
ﬁndings are diﬃcult to reconcile with the anxiogenic
activity of 5-HT2C and the anxiolytic or mixed eﬀects of
5-HT2A and 5-HT1A receptor activation, it is likely that
these divergent roles reﬂect the high complexity of the
circuits for emotional regulation, as well as the diﬀerent
patterns of 5-HT receptor neuronal distribution (Holmes,
2008). Of the other 5-HT receptors, 5-HT3, 5-HT4 and 5-
HT7 have been shown to be fairly abundant in the
amygdala (Waeber et al., 1994; Reynolds et al., 1995;
Gustafson et al., 1996; Miquel et al., 2002; Varna¨s
et al., 2004), but their role in behavioural regulation
awaits further examination.
The 5-HT-ergic system in the NAc. The NAc receives
an extensive, dense innervation by 5-HT-ir axons, which
are tortuous and of consistent morphology (Van
Bockstaele and Pickel, 1993). Both the NAc core and
shell are densely innervated by 5-HT-ergic projections
from the cell bodies in the dorsal raphe; these
projections diﬀer in regional distribution, morphology,
and 5-HTT expression, and can be divided into two
distinct types of 5-HT axons (Brown and Molliver, 2000).
Furthermore, within the NAc, the shell contains a higher
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density of 5-HT axons than the core (Brown and Molliver,
2000). The NAc contains several types of 5-HT receptors.
5-HT1A receptors are expressed in very low levels (Aznar
et al., 2003), while 5-HT1B receptors are expressed on the
soma of GABA-ergic neurons, as well as on the terminals
of the axons that project to the ventral tegmental area
(VTA) (Morikawa et al., 2000). Moreover, 5-HT1B
heteroreceptors are also distributed in pre-synaptic
glutamate elements (Muramatsu et al., 1998). Both 5-
HT2A and 5-HT2C receptors are expressed in moderate-
to-high abundance within both the cell body and
terminal regions of the NAc (Di Matteo et al., 2008; Di
Giovanni et al., 2011). Investigations on the role of 5-
HT2A/2C receptors in the NAc have revealed a complex
scenario, with opposing eﬀects for 5-HT2A and 5-HT2C
receptors (Robinson et al., 2008). In addition, 5-HT4 and
5-HT6 receptors have been shown to be highly
abundant in the NAc (Compan et al., 1996; Ge´rard
et al., 1997; Bonaventure et al., 2000; Hamon
et al.,1999; Varna¨s et al., 2003; Marazziti et al., 2012),
although their functional roles in this area remain largely
elusive.
The role of 5-HT1 receptors in aggression and suicide
The 5-HT1 receptor class is comprised of ﬁve receptor
subtypes (5-HT1A, 5-HT1B, 5-HT1D, 5-ht1E and 5-ht1F),
which, in humans, share 40–63% overall sequence
identity, and couple preferentially, although not
exclusively, to Gi/o proteins to inhibit cAMP formation.
While no physiological role has been found for the 5-
ht1E and 5-ht1F receptors, the function of 5-HT1A, 5-HT1B
and 5-HT1D receptors has been demonstrated in many
tissues across various species (Di Giovanni et al.,
2008a). Although all 5-HT receptor subtypes are
localized post-synaptically on 5-HT target cells
(including all key regions involved in hostile and suicidal
behaviours), the 5-HT1A and 5-HT1B subtypes are also
present in the pre-synaptic elements of 5-HT neurons.
In the raphe´ nuclei, 5-HT1A autoreceptors are localized
on 5-HT cell bodies and dendrites; conversely, 5-HT1B
receptors are expressed pre-synaptically on 5-HT nerve
terminals, where they subserve the regulation of 5-HT
release (Di Giovanni et al., 2008a).
5-HT1A receptors. The implication of 5-HT1A receptors
in aggression and suicide is supported by numerous lines
of evidence. In particular, several studies have
documented that 5-HT1A receptor agonists attenuate
oﬀensive-aggressive (but not defensive) responses in
animal models, even at doses that do not appear to
cause motor impairments (Olivier et al., 1989; White
et al., 1991; Yoshimura and Ogawa, 1991; Sanchez
et al., 1993; Bell and Hobson, 1994; Muehlenkamp
et al., 1995; Lopez-Mendoza et al., 1998). The eﬀects of
5-HT1A agonists on the modulation of aggressive
responses have been shown to depend on the
activation of multiple populations of 5-HT1A receptors,
located across several brain regions, including
periaqueductal gray (PAG) (Beckett et al., 1992; De
Almeida and Lucion, 1997; Mann et al., 2009), raphe´
nuclei (Mos et al., 1993; da Veiga et al., 2011), medial
septal area (De Almeida and Lucion, 1997) and ventral
OFC (Centenaro et al., 2008). While the administration
of 5-HT1A receptor antagonists blocks the anti-
aggressive eﬀects of 5-HT1A receptor agonists (Sanchez
and Hyttel, 1994) [but see also (Pruus et al., 2000) for
contrasting results], these compounds elicit no
signiﬁcant eﬀects on oﬀensive, defensive and social
behaviours (Lopez-Mendoza et al., 1998; Bell et al.,
1999).
In general, the anti-aggressive eﬀects of systemic 5-
HT1A receptor agonists are likely to mostly reﬂect the
anxiolytic eﬀects of autoreceptor activation, in
consideration of the predominance of this subpopulation
of 5-HT1A receptors, as well as the well-known role of
anxiety and fear as primary triggers for aggressive
responses. In this perspective, it is possible that the
selective activation of post-synaptic 5-HT1A receptors in
speciﬁc forebrain areas may lead to diﬀerent modulatory
eﬀects on hostile behaviours. Accordingly, rodents
genetically selected for high levels of aggressive
behaviour exhibit distinct alterations of expression and
sensitivity of 5-HT1A receptor across cortical and
subcortical regions (Korte et al., 1996; Popova et al.,
2005; Caramaschi et al., 2007; Popova et al., 2007).
Most studies have indicated that aggressive animals
and individuals exhibit blunted behavioural and
neuroendocrine responses to 5-HT1A receptor agonists
(Coccaro et al., 1990; Cleare and Bond, 2000; Popova
et al., 2005); in addition, the levels of lifetime aggression
were negatively correlated with overall levels of 5-HT1A
receptor binding (Parsey et al., 2002). However, it
should be noted that aggressive subjects were also
reported to exhibit higher 5-HT1A receptor binding levels
in the prefrontal and anterior cingulate cortex (Witte
et al., 2009), probably in view of the diﬀerential role of
auto- and heteroreceptors in the regulation of aggression.
The potential involvement of 5-HT1A receptors in
suicidal behaviours has been studied through post-
mortem brain assessments of the kinetic characteristics
of these receptors in suicide victims. The results of
these studies, however, are often aﬀected by a number
of experimental confounds, such as the lack of
adequate controls or the comorbidity of suicide with
other anxiety and mood disorders, whose
pathophysiology may reﬂect diﬀerent (and sometimes
opposite) patterns of 5-HT-ergic alterations than those
typically associated with aggression. For example, 5-
HT1A binding was found to be increased in the dorsal
and ventral DRN (Stockmeier et al., 1998) and cortex
(Arango et al., 1995) of suicidal subjects with major
depression; conversely, another study found no
alterations in binding to 5-HT1A receptors in 5-HT-ergic
terminal areas, such as frontal and occipital cortices,
hippocampus and amygdala in depressed suicide
victims (Lowther et al., 1997). In addition to the
methodological caveats listed above, these
discrepancies may also reﬂect diﬀerent inﬂuences of
gender-related factors (Anisman et al., 2008).
The potential implication of 5-HT1A receptors in
suicide has also been analysed with genetic
approaches. 5-HT1A receptor is coded by HTR1A, an
164 M. Bortolato et al. / Neuroscience 236 (2013) 160–185
intronless 2.1 kb gene located at position 5q11.2-q13,
whose expression is likely regulated by two transcription
factors: Nuclear-deformed epidermal auto regulatory
factor-1 (NUDR/Deaf-1) and Hes5 (Lemonde et al.,
2003; Czesak et al., 2006; Szewczyk et al., 2009)
(Table 1). NUDR/Deaf-1 is a repressor at
somatodendritic 5-HT1A receptors (Lemonde et al.,
2003), but serves as a transcription enhancer in non-5-
HT-ergic neurons that express post-synaptic 5-HT1A
receptors. Although several single nucleotide
polymorphisms (SNPs) have been found in HTR1A
(Drago et al., 2008), the best-characterized one is C-
1019G (rs6295), a functional polymorphism in the
promoter region that regulates gene expression
(Lemonde et al., 2003). In particular, it has been
suggested that the G-1019 variant may modulate
negatively the function of NUDR/Deaf-1 on HTR1A
(Lemonde et al., 2003), possibly leading to
compensatory increases in expression of pre-synaptic 5-
HT1A but decreases in expression of the post-synaptic
5-HT1A receptors in G-1019 allele carriers (Albert and
Francois, 2010). Nevertheless, it should be noted that
no signiﬁcant association was found between the C-
1019G genotype and the regional binding potential of
two selective 5-HT1A antagonists,
11C-WAY100635
(David et al., 2005) or 18F-MPPF (Lothe et al., 2010)
using positron emission tomography (PET) in healthy
subjects.
Among the many studies conducted on potential
associations between HTR1A variants and suicide in
Caucasian (Lemonde et al., 2003; Videtic et al., 2006;
Wasserman et al., 2006; Serretti et al., 2007, 2009) and
Japanese (Nishiguchi et al., 2002; Ohtani et al., 2004)
populations, only one (Lemonde et al., 2003) has
documented a signiﬁcant association between higher
frequency of G-1019 allele and GG genotype in patients
with depression and suicide victims than in non-suicidal
healthy controls. The authors posited that this
association may be explained by a reduction of 5-HT-
ergic activity in G carriers due to the inhibitory actions of
this variant on NUDR/Deaf-1-mediated repression of 5-
HT1A autoreceptors (Lemonde et al., 2003). Notably,
recent evidence has documented an association
between homozygosity for the G variant and
impulsiveness (Benko et al., 2010), a trait typically
linked to reduced 5-HT-ergic activity.
In summary, the available evidence on the implication
of 5-HT1A receptors appears to converge on the idea that
IABs may be associated with a reduced activity and/or
expression of the autoreceptors. Functional studies
support that these receptors may not play a primary
causal role in impulsivity and aggression. However, their
key involvement in anxiety regulation and in the
adaptive responses to abnormalities of 5-HT-ergic
homoeostasis may highlight them as attractive
therapeutic targets to reduce the impact of the
conditions that trigger explosive and violent behaviours.
Further studies will be needed to elucidate the nature of
the multiple discrepancies emerging from the preclinical
and clinical literature, as well as the putative roles of
pre- and post-synaptic 5-HT1A receptors in the
regulation of violent and suicidal behaviours, also with
respect to multiple comorbid entities.
5-HT1B receptors. In rodents, activation of 5-HT1B
receptors induces a marked reduction of escalated
aggression in a highly speciﬁc fashion, which appears to
be dissociated from alterations of exploration,
locomotion and anxiety-related behaviours (Miczek
et al., 1989; Sijbesma et al., 1990; Mos et al., 1992; Bell
et al., 1995; Fish et al., 1999; de Almeida et al., 2001;
Muehlenkamp and Gutierrez, 2004). The systemic
eﬀects of 5-HT1B receptor agonists are reproduced by
microinjections of these compounds in the ventral OFC
and raphe nuclei, but not infralimbic PFC (De Almeida
et al., 2006; Bannai et al., 2007; Centenaro et al.,
2008). The mechanism underpinning the role of 5-HT1B
in the modulation of reactive aggression may reﬂect the
involvement of post-synaptic heteroceptors (Mos et al.,
1992; Olivier, 2004) and pre-synaptic autoreceptors
(Clark and Neumaier, 2001; de Boer and Koolhaas,
2005), probably in relation to diﬀerent facets of
aggressive conduct. This pharmacological evidence is
complemented by the ﬁnding of overt impulsive and
antagonistic behaviours, behavioural disinhibition and
increased alcohol intake (Saudou et al., 1994; Crabbe
et al., 1996; Risinger et al., 1999; Bouwknecht et al.,
2001) in 5-HT1B knockout (KO) mice. Collectively, these
Table 1. Gene structure and regulation of key serotonergic genes in humans
Gene organization Key transcription factors
5-HT1A Single exon (intronless) Sp1, Deaf-1, Freud-1, NRSF, AP-1, CREB, MAZ (Pur-1, Zif87), NFKB, c-Jun
5-HT1B Single exon (intronless) GR, c-Fos, c-Myc
5-HT2A Three exons Sp1, PEA3, AP-1, STAT-3
5-HT2C Four exons CUTL-1
5-HT3A Nine exons GR, NRSF
5-HT3B Eight exons IRF-7A, POU2F2, Meis-1, Oct-B1
5-HT4 At least 10 exons (multiple splice variants) POU2F1, POU2F2, GCNF, Oct-B1
5-HT6 Three exons NRSF1, NRSF2, CREB
5-HT7 Four exons (multiple splice variants) Sp1, CREB
TPH1 11 exons NF-Y, Sp1, TBP, TFIID
TPH2 11 exons POU3F2, NRSF, GR
5-HTT 14 exons YB-1, CTCF, GR, NFKB
MAOA 15 exons Sp1, R1, GR, Egr-1, c-Jun, AP-1
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preclinical results support a highly more speciﬁc and
direct role of these receptors in the pathophysiology of
reactive aggression, suicidal behaviour and alcoholism
(Soyka et al., 2004; Cao et al., 2011).
The human 5-HT1B receptor is a 390 amino acid-long
peptide, encoded by HTR1B, an intronless gene (1.1 kb
long) located on chromosome 6 (6q14.1) (Sanders
et al., 2001) (Table 1). Seventy-two polymorphisms
have been discovered in the coding sequence and
surrounding 50 and 30 untranslated regions. Using
denaturing gradient gel electrophoresis (DGGE),
Sanders and colleagues (Sanders et al., 2001)
characterized 12 SNPs and two insertion/deletion (INS/
DEL) polymorphisms within the HTR1B gene. The INS/
DEL polymorphisms are 179INS/DEL-178 and
182INS/DEL-181. Among SNPs, G-511T and T-216G
are detected in the 50 (Nothen et al., 1994; Sanders
et al., 2001) and A-161T in 30 noncoding regions
(Sanders et al., 2001). Four SNPs are synonymous or
silent mutations: C129T (Ser43Ser), G276A (Ala92Ala),
C705T (Ala235Ala) and G861C (Val287Val)
(Lappalainen et al., 1995; Ohara et al., 1996; Cargill
et al., 1999; Sanders et al., 2001). The latter genotype
is in almost complete linkage disequilibrium with C129T
(Huang et al., 1999) and T317G (Sanders et al., 2001),
and may be linked to functional diﬀerences. In fact, C
allele carriers have been shown to display lower binding
of 3H-5-HT to 5-HT1B receptors (Huang et al., 1999).
Other non-synonymous polymorphisms have been
found to change the amino acids in second (T371G;
Phe124CysT), ﬁfth (T655C; Phe219Leu) and seventh
(A1099G; Ile367Val9) transmembrane and intracellular
C terminal (G1120A, Glu374Lys), His452Tyr) regions of
5-HT1B receptors (Sanders et al., 2001).
The association studies that investigated allelic
variability at the HTR1B in suicide attempters and
suicide completers have led to inconsistent results. No
association was found between genotype or allele
frequency of G861C or A-161T polymorphisms and
suicide or suicide history in Caucasians of German
(Rujescu et al., 2003; Stefulj et al., 2004), Croatian
(Stefulj et al., 2004), Slovenian (Videtic et al., 2006) and
French Canadian (Turecki et al., 2003) origin, as well as
in African American (Huang et al., 1999; Huang et al.,
2003), Japanese (Nishiguchi et al., 2001), or Han
Chinese (Hong et al., 2004; Tsai et al., 2004) subjects.
In contrast, New et al. (2001) found that Caucasian
patients with personality disorders and a history of
suicide attempts had a higher frequency of the G allele
of G861C polymorphism than patients without a suicide
history. Another study reported an association between
the T allele in the A-161 T polymorphism and suicide or
IAB. However, no association was found with the other
four SNPs (T261G, C129T; G861C; A1180G) (Zouk
et al., 2007). Other variants associated with microRNA-
directed silencing of 5-HT1B transcription were recently
correlated with higher risk for conduct disorder and
greater anger and hostility in young men (Jensen et al.,
2009; Conner et al., 2010).
Taken together, preclinical and clinical evidence
appears to concur in assigning a putative causal role for
hypofunctional 5-HT1B receptors in IABs. Despite these
promising research leads, further studies on the
selective role of pre- and post-synaptic receptors and
clinical studies with a larger number of subjects are
needed to clarify the association between 5-HT1B
receptors and aggressive-impulsive endophenotypes, as
well as their involvement in suicidal behaviours.
The role of 5-HT2 receptors in aggression and suicide
5-HT2 receptors form a closely related subgroup of G-
protein-coupled receptors, functionally linked to the
phosphatidylinositol hydrolysis pathway and currently
classiﬁed as 5-HT2A, 5-HT2B and 5-HT2C subtypes,
based on their close structural homology and
pharmacology (Di Giovanni et al., 2008a). Initial studies
on 5-HT2 receptor signalling showed that these
receptors activate the heterotrimeric G proteins that
contain the aq subunit, thereby stimulating
phospholipase Cb and leading to phosphatidyl inositol
hydrolysis (Di Giovanni et al., 2011). These receptors
also stimulate phospholipase A2 and the NO/cyclic
GMP (cGMP) pathway. However, some diﬀerences in
the signal transduction characteristics of these receptors
have been reported (Imbrici et al., 2000; Di Giovanni
et al., 2011). Studies focusing on the regulation of the 5-
HT2 receptor family have also indicated that 5-HT2
receptors are non-classically regulated and show
constitutive activity (Di Giovanni et al., 2008a, 2011).
5-HT2A receptors. Although both agonists and
antagonists of 5-HT2A receptors have been shown to
reduce hostile behaviours (White et al., 1991; Olivier
et al., 1995; Sakaue et al., 2002) [for contrasting results,
see (Skrebuhhova-Malmros et al., 2000)], the
interpretation of these ﬁndings is often complicated by
the side eﬀects of these compounds, such as the
cognitive deﬁcits induced by 5-HT2A agonists and the
sedative and hypolocomotive eﬀects of their blockers
(de Almeida et al., 2005). Little is currently known about
the roles of diﬀerent regions in the role of 5-HT2A
receptors in aggression; however, local infusion of 5-
HT2 agonists into the PAG was found to attenuate
maternal aggression in rats (de Almeida et al., 2005).
In contrast with evidence on rodents, converging lines
of evidence have pointed to the implication of 5-HT2A
receptors in aggression. For example, 5-HT2A receptor
expression in platelets has been correlated to the
severity of hostile traits (Coccaro et al., 1997); however,
this index has been shown to be unreliable as a
suicidality marker (Lauterbach et al., 2006). Other
studies have identiﬁed inverse correlations between 5-
HT2A expression and activity in the PFC and OFC with
aggression. For example, low levels of 5-HT2A binding
potential have been found in the PFC of violent
aggressive individuals (Meyer et al., 2008). In males, a
negative correlation was found between 5-HT2A binding
in left orbital and medial frontal cortex and aggression
severity (Soloﬀ et al., 2010). In contrast with these data,
prefrontal 5-HT2 binding (as tested by
3H ketanserin)
has been found to be directly correlated with lifetime
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aggression scores in suicidal subjects (but not in their
controls) (Oquendo et al., 2006); furthermore, 5-HT2A
receptor availability in the OFC has been recently
correlated with a state measure of impulsive aggression
(Rosell et al., 2010).
Another important line of research to assess the
implication of 5-HT2A receptors in the pathophysiology
of aggression comes from genetic association studies.
The 64-kb gene coding the 5-HT2A receptor (HTR2A) is
located on the long arm of chromosome 13 at position
13q14-q21 (Sparkes et al., 1991), and is comprised of
three exons and two introns, with translation length of
471 residues (NCBI Gene 2012) (Table 1). A silencer
element found downstream of the second promoter
element suggests that HTR2A contains two alternative
promoters (Myers et al., 2007; Serretti et al., 2007).
Although almost 300 diﬀerent SNPs within HTR2A have
been listed (Serretti et al., 2007; Fanous et al., 2009)
(Table 2), only a few are well-documented (Serretti
et al., 2007):
– two silent mutations in the coding region, T102C and
C516T (Spurlock et al., 1998);
– nine polymorphisms are located in the promoter region
(Myers et al., 2007), the best-characterized of which is
the A-1438G;
– ﬁve non-synonymous polymorphisms in the extracellu-
lar N terminal (polymorphism Thr25Asn), fourth trans-
membrane (Ile197Val) and intracellular C terminal
(Ser421Phe, Ala447Val, His452Tyr) regions (Davies
et al., 2006).
The synonymous mutation T102C (rs6313) is located
in the ﬁrst exon of the HTR2A. The substitution of base
thymine (T) with cytosine (C) encodes in both cases for
the amino acid serine in codon 34 of the HTR2A and do
not change the amino acid sequence of the protein.
Although T102C represents a silent polymorphism, it is
positioned close to the promoter region and could be
involved in gene regulation (Serretti et al., 2007) by
changing the secondary structure of the transcript or by
prevention of gene expression by methylation of
cytosine in position 102 (Vaquero-Lorenzo et al., 2008).
The G to A base change at position 1438 (rs6311) is
in total linkage disequilibrium with T to C base change at
silent polymorphism T102C (Spurlock et al., 1998;
Kouzmenko et al., 1999; Ono et al., 2001) implying
these two polymorphisms could be considered together.
The functional role of SNP T102C or A-1438G is not
clear. In healthy individuals, TT carriers were shown to
exhibit a higher number of 5-HT2AR binding sites (Bmax)
in blood platelets (Khait et al., 2005) and brain (Turecki
et al., 1999), as compared with TC and CC genotype
carriers. Post-mortem brain analyses have shown higher
expression of HTR2A mRNA in temporal cortex of
healthy subjects with TT genotype in some (Polesskaya
and Sokolov, 2002) but not all (Bray et al., 2004)
studies. In contrast, the A-1438G genotype was found
to have no association with the 5-HT2AR density in post-
mortem samples of the lateral frontal cortex of
schizophrenia patients and healthy probands
(Kouzmenko et al., 1999).
The 5-HT2A His452Tyr (1354 C/T; rs6314)
polymorphism is positioned in exon 3 of the HTR2A
gene. This missense mutation consists of a C-T base
substitution, resulting in the change of the amino acid
hystidine (His) into tyrosine (Tyr) at position 452 in the
C-terminal region of the 5-HTR2A receptor. The most
common variant is C allele (His452His), while the
frequency of T allele is approximately 9% in Caucasians
(Filippini et al., 2006). The His452Tyr is a functional
polymorphism that regulates the 5-HT2A receptor activity
throughout the regulation of Ca2+ ﬂuctuation in cells
(Ozaki et al., 1997) and activation of phospholipases C
and D (Hazelwood and Sanders-Bush, 2004) with
452Tyr being the less active variant.
Several studies have documented signiﬁcant
associations between the severity or the incidence of
aggression and anger traits with speciﬁc polymorphic
functional variants of the gene encoding for these
receptors, including the SNPs T102C (Assal et al.,
2004) and the A-1438G genotypes (Berggard et al.,
2003). Interesting, the latter polymorphism has been
shown to inﬂuence the risk of impulsive behaviour
(Nomura and Nomura, 2006) and suicidality (Giegling
et al., 2006). Finally, the SNP His452Tyr has been
associated with rule-breaking components of antisocial
behaviour in adolescence, but not physical aggression
(Burt and Mikolajewski, 2008). It should be mentioned,
however, that other studies have failed to identify
associations between genetic variants of 5-HT2A and
aggression in suicide victims (Videtic et al., 2006) and
alcoholic patients (Preuss et al., 2000). Furthermore,
most of the studies failed to ﬁnd a signiﬁcant association
between T102C or His452Tyr and suicidal ideation
(Bondy et al., 2000; Preuss et al., 2000; Fanous et al.,
2009) suicide attempts (Preuss et al., 2000; Arias et al.,
2001; Tan et al., 2002; Oswald et al., 2003; Etain et al.,
2004; Khait et al., 2005; Zalsman et al., 2005; Giegling
et al., 2006; Correa et al., 2007; Saiz et al., 2008;
Zhang et al., 2008), severity of suicidal behaviour (De
Luca et al., 2008a), suicide (Bondy et al., 2000;
Crawford et al., 2000; Faludi et al., 2000; Ono et al.,
2001), suicidal behaviour (Ertugrul et al., 2004; Murphy
et al., 2011) or completed suicide (Turecki et al., 1999).
Few studies found signiﬁcant association between the
Table 2.
Polymorphisms of 5-HT2A References
Promoter region A-1438G, C-1420T, A-1273G, A-1182G, A-783G, G-561A, C-559T, G-400A, A-311G Myers et al., 2007
Coding region Thr25Asn, Ile197Val, Ser421Phe, Ala447Val, His452Tyr Davies et al., 2006
Silent T102C, C516T Spurlock et al., 1998
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T102C CC genotype and suicide in suicide attempters
compared to a healthy control but not psychiatric
controls (Vaquero-Lorenzo et al., 2009), or in depressed
patients with suicide ideation (Du et al., 2000). In
addition, C allele of the T102C was found to represent a
risk factor for depressed patients to attempt suicide
(Arias et al., 2001).
In summary, the involvement of the 5-HT2A receptor in
the enactment of aggressive and impulsive responses
remains poorly understood, in view of experimental
limitations (such as the lack of highly selective 5-HT2A
receptor agonists for experimental studies) and
diﬀerential roles played by these post-synaptic targets
across diﬀerent brain regions. It is likely that regional
subpopulations of 5-HT2A receptors (such as those in
the PFC and OFC) may participate in the emotional and
cognitive appraisal of environmental triggers for
aggressive and suicidal responses, and thus help
convey some of the neurochemical signals related to the
ideation, planning, initiation, execution and extinction of
IABs. The diverse contributions of these regional
subgroups of 5-HT2A receptors may explain the
associations between HTR2A variants and diﬀerent
aspects of aggression and suicidal behaviours.
However, further studies on the functional signiﬁcance
of the diﬀerent clusters of 5-HT2A receptors are needed
to deﬁne the speciﬁc relevance of these targets in IABs
and suicide-related traits, as well as the comorbid
emotional disturbances associated with aggression.
5-HT2C receptors. In contrast with the other major 5-
HT receptors, the role of 5-HT2C receptors in aggression
has long remained elusive, and has been investigated
only recently, thanks to the development of novel
selective ligands. The few data currently available
indicate that stimulation of these targets reduces
aggressive responses and enhances the display of
submissive behaviour (Rosenzweig-Lipson et al., 2007;
Dekeyne et al., 2012; Harvey et al., 2012). These
eﬀects, however, may result from a general
enhancement in social anxiety (Kantor et al., 2000). The
possible implication of the 5-HT2C receptor in suicidal
behaviours has been studied in genetic association
analyses. The gene that codes this receptor (HTR2C) is
located at position Xq24 (Milatovich et al., 1992) and
consists of six exons and ﬁve introns (Xie et al., 1996)
(Table 1). According to NCBI SNP Database, there are
several thousand SNP within HTR2C. Among them, the
best-characterized one is the polymorphism Cys23Ser
(rs6318), consisting of two variants, C and G and
resulting in the change of the amino acid Cysteine into
Serine in the N-terminal region of the protein. Of note,
5-HT2C is altered post-transcriptionally, and diﬀerences
in pre-mRNA editing of 5-HT2C receptors were found
between control subjects and suicidal victims (Gurevich
et al., 2002; Dracheva et al., 2008). In contrast, most
studies failed to identify signiﬁcant associations among
polymorphisms of this receptor and suicidal attempts
(Arias et al., 2001; Turecki et al., 2003; Serretti et al.,
2007; Zhang et al., 2008; Serretti et al., 2009),
completed suicide (Stefulj et al., 2004), the severity of
suicidal behaviours (De Luca et al., 2008b, 2011) or
suicide risk and deliberate self-harm (Pooley et al.,
2003). To the best of our knowledge, only one study
detected a signiﬁcant association between completed
suicide and the variants of the SNP rs6318, with the
excess of GG genotype and allele G in suicide victims
(Videtic et al., 2009).
The role of other 5-HT receptors in aggression and
suicide
5-HT3 receptors. In contrast with the other 5-HT
receptors, 5-HT3 is a pentameric, ion-gated channel that
mediates fast synaptic transmission. In the CNS these
receptors are located in many areas relevant to
emotional regulation, including the neocortex, amygdala,
hippocampus, NAc and brainstem. Of the ﬁve subunits
identiﬁed to date, termed 5-HT3A to 5-HT3E, only the ﬁrst
two (A and B) have been suﬃciently characterized.
Several preclinical experiments have shown that 5-HT3
receptors exert a complex inﬂuence on aggressive
responses in rodents. For example, pharmacological
tests suggest that these receptors participate in alcohol-
and cocaine-induced aggression (Ricci et al, 2004;
McKenzie-Quirk et al, 2005). In general, several 5-HT3
antagonists have been shown to reduce aggression in a
fashion dependent on the genetic background and the
baseline proclivity to engage in ﬁghting behaviour
(McKenzie-Quirk et al, 2005; Cervantes et al, 2010).
Conversely, other lines of evidence indicate that these
compounds are often ineﬃcacious in aﬀecting isolation-
induced aggression (White et al, 1991; Sanchez et al,
1993). Notably, 5-HT3 agonists have also been shown
to exert anti-aggressive properties in some (Poncelet
et al, 1995; Rudissaar et al, 1999), but not all studies
(Ricci et al, 2005).
In contrast with the rich associations between 5-HT3
receptors and aggression, their possible involvement in
suicidal behaviour has been challenged by genetic
association studies (Souza et al, 2011) and post-
mortem assessments of their binding in the cortex of
suicide victims (Mann et al, 1996).
5-HT4, 5-HT6 and 5-HT7 receptors. Our current
knowledge on the 5-HT receptors coupled to Gs
proteins (5-HT4, 5-HT6 and 5-HT7) with respect to the
modulation of aggression and suicide is still
rudimentary. Initial studies appear to implicate a
signiﬁcant up-regulation of 5-HT4 receptors in the frontal
cortex and caudate nucleus of depressed suicide
victims (Rosel et al, 2004). Studies on the C267T
polymorphism of the human 5-HT6 gene have shown a
possible implication of this SNP in the suicide of male
patients (Azenha et al, 2009; but see Okamura et al,
2005 for contrasting ﬁndings). The same SNP was not
found in association with aggressive behaviour in
schizophrenia patients (Tsai et al, 1999). Although the
role of 5-HT7 in aggression and suicidal behaviour
remains elusive, preliminary pharmacological studies
appear to temper the possibility of a direct implication of
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this target in the modulation of aggression (Navarro et al,
2004).
The role of TPH in aggression and suicide
The synthesis of 5-HT depends on the speciﬁc action and
rate-limiting step of the enzyme l-tryptophan-5-
monooxygenase (EC 1.14.16.4), commonly termed
TPH. A member of the aromatic amino acid
hydroxylases (AAAHs) family, TPH converts tryptophan
to 5-hydroxytryptophan (5-HTP) using molecular
oxygen, ascorbic acid, and biopterin. The two TPH
isoenzymes known to date, TPH1 and TPH2 (Walther
et al., 2003), are respectively encoded by genes located
on chromosome 11 and 12 in humans. Although the two
enzymes share considerable sequence identity, their
regulatory domains diﬀer substantially (Murphy et al.,
2008b). As far as their anatomical distribution is
concerned, TPH1 is expressed mostly in peripheral
tissues (with the exception of the pineal gland) while
TPH2 is predominant in the CNS, and typically
expressed in the raphe nuclei as well as the brain areas
targeted by 5-HT-ergic projections (Carkaci-Salli et al.,
2011) (Table 3). The Km of partially puriﬁed TPH for
tryptophan is approximately 30–60 lM. Considering the
brain concentrations of tryptophan, TPH is not expected
to be saturated with substrate, and the formation of 5-
HT in the brain is predicted to rise as the brain
concentration of tryptophan increases (Leathwood and
Fernstrom, 1990). Unfortunately, tryptophan-rich diets
produce a simultaneous increase of peripheral 5-HT,
with important side eﬀects. On the contrary, selective
targeting of TPH2 can selectively boost the synthesis of
5-HT in the brain, increasing the stored amount and
evoked release of the neurotransmitter; this
pharmacological strategy may be highly promising for
the development of novel antidepressants (Torrente
et al., 2012). The product of TPH-mediated reaction, 5-
HTP, is decarboxylated into 5-HT by L-aromatic amino
acid decarboxylase (AADC) (EC 4.1.1.28). Interestingly,
AADC catalyses the decarboxylation of both 5-HTP and
DOPA in catecholaminergic neurons. The gene
encoding the enzyme is referred to as dopa
decarboxylase (DDC), and is located on chromosome 7
in humans (Scherer et al., 1992). Almost 30 genetic
mutations of DDC have been characterized in patients
with AADC deﬁciency (Haavik et al., 2008).
Both clinical and preclinical evidence indicate that
IABs and other aggressive phenotypes are modulated
by both TPH isoenzymes. In laboratory animals, acute
pharmacological inhibition of TPH typically enhances
inter-male aggression by reducing 5-HT levels (Vergnes
et al., 1986). Because of its role as the rate-limiting
enzyme of 5-HT biosynthesis, TPH expression and
activity are normally aﬀected by chronic exposure to
environmental conditions that facilitate or reduce
aggression, such as repeated victory or defeat
(Amstislavskaya and Kudryavtseva, 1997), or by genetic
selection for aggressiveness or docility (Popova et al.,
1991). In line with the general variability observed
across most 5-HT targets, the heterogeneity of these
variations documented by diﬀerent studies is likely to
signify that changes in TPH may reﬂect compensatory
adaptive mechanisms probably aimed at restoring 5-HT
homoeostasis. Notably, mice hypomorphic or deﬁcient in
TPH2 were recently reported to exhibit high aggression,
as well as other emotional alterations (Beaulieu et al.,
2008; Mosienko et al., 2012). In contrast, the G allele of
the murine C1473G polymorphism was found to be
associated to lower TPH2 activity in the midbrain
(Kulikov et al., 2005), as well as lower aggression and
reduced depression-like behaviour in the forced swim
test (Kulikov et al., 2005; Osipova et al., 2009).
Most clinical studies have been focused on genetic
associations between SNP variants of the TPH1 gene
and several indices of aggressive personality or
prevalence of suicidal behaviour. For example, the L
allele of the A218C polymorphism located in intron 7 of
TPH1 was associated with higher Buss-Durkee Hostility
Inventory (BDHI) scores (New et al., 1998), and
occurred with higher frequency in violent males (Nolan
et al., 2000). Subsequent analyses, however, found that
carriers of the U allele had a greater tendency to
express their anger outwardly, and experience
Table 3.
Tryptophan hydroxylase isoform
TPH1 TPH2
Location
Enterochromaﬃn cells, pineal body Brain
Physiological functions of serotonin
Melatonin synthesis Food intake and body weight
Vasoconstriction Sleep
Haemostasis Behaviour
Immune system Mood
Intestinal motility Thermoregulation
Serotonin in pathology of diseases
Migraine Migraine
Carcinoid Neuropsychiatric disorders
Obesity
The two tryptophan hydroxylase isoforms, their location and corresponding physiological and patho-
logical function of central or peripheral serotonin systems.
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unprovoked anger (Manuck et al., 1999). The same
genotype was found to be associated with impulsive
behavioural tendencies (IBTs) (Staner et al., 2002) and
anger-related traits (Rujescu et al., 2002).
The A779C polymorphism was found to be
signiﬁcantly related to aggressive hostility, with the
highest aggression levels for the genotype AA and the
lowest aggression levels for the genotype CC in
volunteers (Hennig et al., 2005). Conversely, another
study on Korean individuals found that CC homozygotes
in the major depression disorder group scored
signiﬁcantly higher in terms of verbal aggression and
total aggression than A carrier genotypes, regardless of
sex and age (Koh et al., 2012).
Several post-mortem studies have found an increased
expression of TPH2 mRNA (Bach-Mizrachi et al., 2006,
2008; Perroud et al., 2010) and higher levels of the
TPH2 protein (Underwood et al., 1999; Boldrini et al.,
2005; Bonkale et al., 2006) in the brain of depressed
suicide victims. Bach-Mizrachi et al. (2008) proposed
that a higher TPH2 expression could be a response to
deﬁcient 5-HT levels in the brains of depressed suicides.
The human TPH2 gene covers about 93.5 kb, consists
of 11 exons, and exhibits hundreds of SNPs and multiple
post-translational modiﬁcations (Zhang et al., 2006). Most
of the detected sequence variants in the TPH2 gene are
SNPs, mainly located in noncoding regions of the gene.
In the association and linkage disequilibrium study on
suicide victims, evaluating 10 SNPs in the TPH2, a
signiﬁcant association between SNP rs1386494 in intron
5 and suicide was found (Zill et al., 2004). A haplotype
analysis showed a signiﬁcant association with suicide
for three haplotypes (Zill et al., 2004). This result could
not be replicated by Lopez de Lara et al. (Lopez de
Lara et al., 2007). These last authors (Lopez de Lara
et al., 2007) investigated 14 SNPs (nine intronic, two
exonic and three SNPs in the 50 upstream region of the
gene). They found a signiﬁcant overrepresentation of
alleles T, G, G and C of the SNPs rs4448731 (TPH2
upstream region), rs6582071 (TPH2 upstream region),
rs4641527 (intron 1), and rs1386497 (intron 8),
respectively, in depressed suicide completers. No
association was found regarding functional SNP
G1463A (rs120074175) in exon 11 (Lopez de Lara
et al., 2007), similarly to the ﬁndings of other studies
(Garriock et al., 2005; Delorme et al., 2006). Results
obtained for rs6582071 were not conﬁrmed by other
studies (Mouri et al., 2009; Must et al., 2009). Most of
the studies that have focused on the SNPs placed in the
TPH2 upstream region, that have an impact on protein
expression, relate to rs4570625 (located in the promoter
region of the gene). Yoon et al. (Yoon and Kim, 2009)
showed a positive association of rs4570625 with suicide
attempt and concluded that the observed increased
frequency of the G allele may be associated with
elevated suicidal behaviour. Several other studies,
however, did not conﬁrm this association (Zhou et al.,
2005; Zill et al., 2007; Mouri et al., 2009; Stefulj et al.,
2011). The human TPH2 promoter polymorphism
rs11178997 is another SNP in the promotor region that
has an impact on TPH2 expression (Chen et al., 2008),
but according to results obtained by several diﬀerent
groups (De Luca et al., 2005b; Zhou et al., 2005; Lopez
et al., 2007; Must et al., 2009), it has no impact on
suicide attempt and completion. SNP rs7305115, which
is located at approximately 1077 bp from the 7 exon,
could be involved in the control of TPH2 mRNA
expression (Lim et al., 2007) and it could also inﬂuence
suicidal behaviour (Ke et al., 2006; Zhang et al., 2010).
Grohmann et al. (2010) reported a higher frequency of
rs4290270 AA genotype in suicide completers and
found evidence that rs4290270 aﬀects TPH2 alternative
splicing and editing. TPH2 SNP variants have also been
recently associated with the association of aﬀective
lability, aggression and suicidal behaviour (Perez-
Rodriguez et al., 2010).
Taken together, emerging evidence suggests that
TPH2 may have a direct implication on the
pathophysiology of IABs and other aspects of
aggression and suicidality. However, evidence in this
respect is still preliminary and awaits more thorough
characterization by means of selective inhibitors and
brain-regional infusion studies in animal models, as well
as studies on potential associations between its as-yet
poorly examined SNPs, and speciﬁc endophenotypes of
aggression (also in association to environmental triggers
and gender-speciﬁc factors).
The role of 5-HTT in aggression and suicide
The extracellular levels of 5-HT are regulated by 5-HTT,
both in central and peripheral 5-HT-ergic subsystems
(Lesch et al., 1993b). The human gene for 5-HTT,
termed SLC6A4, is located in the chromosome 17, and
codes a protein comprised of 630 amino acids with 12
transmembrane domains (Mayser et al., 1991; Lesch
et al., 1993a). 5-HTT is localized on the terminals of 5-
HT neurons, where it ensures the recapture of 5-HT. It
is the pharmacological target of selective reuptake
inhibitors (SSRIs) mainly used as antidepressants
(Geddes et al., 2000).
The implication of 5-HTT in the regulation of
aggressive behaviour is cogently indicated by the well-
documented anti-aggressive eﬀects of SSRIs, both in
psychiatric patients and healthy volunteers (Coccaro
et al., 1997; Walsh and Dinan, 2001; Reist et al., 2003;
Bond, 2005; Barkan et al., 2006; Blader, 2006; Carrillo
et al., 2009). Similarly to the time-frame of the
antidepressant eﬀects of these agents, their anti-
aggressive potential is generally observed only following
prolonged treatment (2-3 weeks), likely as a result of
neuroplastic adaptive mechanisms resulting in receptor
desensitization or synaptic remodelling. Chronic SSRI
administration has been shown to restore the metabolic
activity of the PFC (New et al., 2004), suggesting that
the reduction in aggression induced by these
compounds may depend on the integrity of the
prefrontal function, which is essential for impulse control
as well as emotional appraisal of social contexts. In
support of this possibility, Troisi and colleagues (Troisi
et al., 1995) documented that, in a subset of patients
aﬀected by mental retardation and epilepsy, chronic
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treatment with ﬂuoxetine led to enhanced, rather than
reduced aggressiveness.
The evidence on the eﬀects of SSRIs on aggression is
generally paralleled by ﬁndings in rodents (Olivier et al.,
1989; Delville et al., 1996; Pinna et al., 2003; Carrillo
et al., 2009). However, a critical diﬀerence between the
eﬀects of SSRIs in humans and most rodent models of
aggression is that, in the latter, the ameliorative eﬀects
of these compounds is already signiﬁcant after acute
administration, and sometimes even reversed after
chronic treatment (Mitchell et al., 1991; Mitchell and
Redfern, 1992; Mitchell, 2005). While the neurochemical
underpinnings of these phenomena remain poorly
understood, these divergent ﬁndings may reﬂect the
intrinsic limitations of the experimental manipulations
used to elicit aggressive reactions in rodents, such as
social isolation (which may lead to enhanced territorial
behaviour and instrumental aggression).
Notably, genetic deﬁciency of 5-HTT in mice results in
lower levels of aggression in the resident-intruder
paradigm, with longer latency to the ﬁrst attack and
fewer ﬁghting encounters, but no changes in social
investigations (Holmes et al., 2002). 5-HTT KO mice
display lower 5-HT reuptake and higher 5-HT forebrain
concentrations compared to wild-type (WT) conspeciﬁcs
(Mathews et al., 2004). In addition, these mutants
exhibit improved inhibitory control (Homberg et al.,
2007) and are less likely to obtain a dominant status in
comparison with WT mice. In this respect, it is worth
noting that the levels of aggression shown by 5-HTT KO
mice are greatly inﬂuenced by the opponent’s
behaviour, as well as the venue of the aggressive
encounter (Jansen et al., 2011).
While few authors have investigated platelet 5-HTT
binding as a potential biomarker of aggression with
variable results (Barkan et al., 2006; Coccaro et al.,
2010), recent studies have shown higher 5-HTT binding
in the brainstem in impulsive and aggressive humans
(Rylands et al., 2012) and rats (Kerman et al., 2011),
suggesting that this index may be a valuable cross-
species parameter for translational studies.
The role of 5-HTT in the modulation of aggression is
also strongly supported by several genetic studies on
SLC6A4 polymorphic variants. SLC6A4 is among the
most frequently studied candidate genes for psychiatric
disorders and suicidal behaviour (Lesch and Gutknecht,
2005). The best-characterized polymorphism of 5-HTT
is 5-HTTLPR (5-HTT-linked promoter region), a 43-bp
INS/DEL variation within the promoter region, which is
thought to regulate variations in transcriptional activity:
the long variant (L allele, with 16 repeats) has higher
basal activity and expression than the short variant (S
allele, with 14 repeats) (Heils et al., 1996; Lesch et al.,
1996). Another recently detected SNP (rs25531)
consisting in an A? G substitution in the 6th motif
upstream the 5-HTTLPR locus, has been shown to
inﬂuence the binding for Activator Protein-2 (AP2), a
transcriptional suppressor of the 5-HTT (Kraft et al.,
2005). The G allele of the rs25531 is associated with
low level of 5-HTT mRNA expression, which makes it
similar to allele S of the 5-HTTLPR, while the A allele is
associated with high level of mRNA expression (Hu
et al., 2006), which is similar to allele L of the 5-
HTTLPR. Therefore, more recent studies analyse 5-
HTTLPR and rs25531 as a triallelic system (De Luca
et al., 2008a; Bozina et al., 2012), in which the LA allele
(allele L with rs25531 A variant) is associated with high
5-HTT functionality, while the S and LG (L allele with
rs25531 G variant) alleles are linked to lower 5-HTT
expression (Hu et al., 2006; Zalsman et al., 2006;
Bozina et al., 2012).
Most genetic studies have pointed to an association
between the S haplotype of 5-HTTLPR and the
prevalence or severity of several emotional
disturbances, encompassing anxiety, depression,
impulsivity, hostility, anger, novelty-seeking behaviour
and worse therapeutic responsiveness to SSRIs (Evans
et al., 1997; Hallikainen et al., 1999; Lesch and
Merschdorf, 2000; Courtet et al., 2001; Gerra et al.,
2005; Silva et al., 2010). The same variant has been
linked to aggressive reactivity in children and conduct
disorder in adolescents (Beitchman et al., 2006;
Haberstick et al., 2006; Sakai et al., 2006). In addition,
the presence of one or two S alleles of 5-HTTLPR has
been associated with most suicidal behaviours, including
violent suicide (Bellivier et al., 2000; Campi-Azevedo
et al., 2003; Bondy et al., 2006; Li and He, 2007),
violent or impulsive suicide attempts (Baca-Garcia et al.,
2005; Neves et al., 2008; Neves et al., 2010) re-
attempted suicidal attempts (Courtet et al., 2004),
suicide attempts in abused children (Gibb et al., 2006),
suicide attempts with high medical damage (Wasserman
et al., 2007), and a life-time risk of suicide attempts in
male subjects (Limosin et al., 2005).
Nevertheless, other studies found no signiﬁcant
association between 5-HTTLPR and suicidal attempts
(Gerra et al., 2004; Shen et al., 2004; De Luca et al.,
2005b; De Luca et al., 2006; Zalsman et al., 2006;
Chen et al., 2007; Roy et al., 2007; Bah et al., 2008;
De Luca et al., 2008a; Akar et al., 2010), suicide history
(Yen et al., 2003; Malloy-Diniz et al., 2011), family
history of suicidal behaviour (Correa et al., 2004),
severity of suicidal attempt (De Luca et al., 2005b) or
completed suicide in suicidal victims (Mann et al., 2000;
Pungercic et al., 2006). The lack of a signiﬁcant
association between suicide attempt or ideation and 5-
HTTLPR was conﬁrmed in the large European
multicenter case-control (Mendlewicz et al., 2004), or
twin sample (Coventry et al., 2010), evaluating both
bilalleic (5-HTTLPR) and triallelic (5-
HTTLPR+ rs25531) classiﬁcation (De Luca et al.,
2006; Coventry et al., 2010).
These discrepancies might be partially explained by
the numerous methodological issues such as lack of
statistical power, diﬀerences in the diagnostic criteria
and inclusion of patients with diﬀerent psychiatric
diagnoses and healthy control subjects and diﬀerent
severity of suicidal behaviour (ranging from suicidal
ideation to completed suicide). In addition, studies
evaluating biallelic 5-HTTLPR classiﬁcations may yield
diﬀerent results from those using triallelic models
(Bozina et al., 2012).
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An alternative explanation for the numerous
discrepancies in association studies may lie in the
possibility that multiple biological and environmental
factors may moderate the relation between 5-HTTLPR
and suicide or aggression. For example, Cadoret et al.
(2003) have suggested that, in contrast with males,
female carriers of short variants display lower levels of
conduct disorder and aggressiveness. On the other
hand, the LL genotype was also signiﬁcantly associated
with suicide attempts in women, but not in men
(Gaysina et al., 2006).
Ethnic (Noskova et al., 2008) and/or socio-cultural
components may also diﬀerentially inﬂuence the
association of 5-HTLLPR polymorphic variations and
aggression; for example, no signiﬁcant correlation was
identiﬁed in groups of African-Americans (Patkar et al.,
2002) or Spanish suicide attempters (Baca-Garcia et al.,
2004), and only a marginal association between the s
variant and aggressiveness was found in Korean
schizophrenia patients (Kim et al., 2009).
Additional lines of research suggest that the
relevance of 5-HTLLPR with respect to aggression
may be related to speciﬁc gene  environment
interactions; for example, carriers of the short-allele
variant were found to exhibit greater proclivity to
aggression and suicidal ideation in response to
stressful events (Caspi et al., 2003; Verona et al.,
2006; Conway et al., 2012). These data may suggest
that 5-HTT genotype may exert a direct inﬂuence on
cognitive and emotional modalities of stress-coping,
which may result in increased aggression, poor
impulse control and suicidal tendencies in the
presence of unfavourable psychosocial contingencies.
Thus, the association between the S variant and
aggression may depend on the function of the
prefrontal cortex, in a fashion similar to what could
be postulated for the therapeutic eﬀects of SSRIs.
Accordingly, several studies have shown that, in
Alzheimer’s disease patients or individuals with
intellectual disabilities, aggression is associated with
the long allelic variant, rather than the short one
(Sukonick et al., 2001; Sweet et al., 2001; May
et al., 2010).
A variable number tandem repeat (VNTR)
polymorphism has been found in intron 2 of the 5-HTT,
containing 9, 10 or 12 copies of a 17-bp repeat element.
It is assumed that the transcriptional regulatory activity
depends on the number of repeat copies; thus, the 12-
repeat allele has higher activity than the 10- and the 9-
alleles (Fiskerstrand et al., 1999; MacKenzie and Quinn,
1999). The association between 5-HTT VNTR intron 2
and suicide has been investigated (Bellivier et al., 2000;
Ho et al., 2001; Hranilovic et al., 2003; Yen et al., 2003;
Jernej et al., 2004; Shen et al., 2004; De Luca et al.,
2005a; De Luca et al., 2006; Gaysina et al., 2006;
Pungercic et al., 2006; De Luca et al., 2007; Lopez de
Lara et al., 2007; Bah et al., 2008), yielding mixed
results. Whereas one study found a protective eﬀect of
the 10-repeat allele against suicidal behaviour and an
association of this variant with lower suicidal scores in
schizophrenic patients (De Luca et al., 2006), another
report documented that the same allele was more
common among depressed suicide attempters (Lopez
de Lara et al., 2007).
The role of MAO-A in aggression and suicide
Monoamine oxidases (MAOs; E.C. 1.4.3.4) are ﬂavin–
adenosine–dinucleotide (FAD)-containing enzymes that
catalyse the degradation of biogenic amines. The two
MAO isoforms, termed MAO-A and MAO-B, diﬀer in
molecular weight (527 and 520 amino acid,
respectively), inhibitor sensitivities and substrate
aﬃnities: while MAO-A prefers 5-HT, norepinephrine
and epinephrine, MAO-B has a high aﬃnity for b-
phenylethylamine. In most vertebrate species, dopamine
metabolism is served by both forms. Both MAOs are
coded by genes located in the X chromosome, but are
transferred to the outer mitochondrial membrane. The
distribution patterns of MAOs in the organism are also
strikingly divergent. Within the CNS, MAO-B is
expressed at highest levels in the cell bodies of 5-HT-
ergic neurons, histaminergic neurons and glial cells,
while MAO-A is primarily expressed in
catecholaminergic neurons (Westlund et al., 1988;
Saura et al., 1994; Luque et al., 1995; Jahng et al.,
1997). In the peripheral tissues, MAO-A is particularly
abundant in the placenta (Egashira and Yamanaka,
1981), liver, and gastro-intestinal tract, while MAO-B is
the only isoform expressed in platelets and lymphocytes
(Bond and Cundall, 1977). Human MAO-A and MAO-B
show 70% homology in amino acid sequence (Chen and
Shih, 1998).
Multiple lines of evidence have indicated that MAO-A
deﬁciency leads to impulsive aggression in animals and
humans. The nonsense mutation of MAOA gene results
in Brunner syndrome, a X-linked condition characterized
by marked proclivity to engage in violent and antisocial
behaviours (including attempted rape, murder and
arson) in response to relatively minor stressors, as well
as borderline mental retardation, stereotyped hand
movements and sleep disturbances. These behavioural
abnormalities are accompanied by high 5-HT and low
urinary 5-HIAA concentrations (Brunner et al., 1993a;
Brunner et al., 1993b). The symptoms of Brunner
syndrome are strikingly similar to the aberrant
phenotypes of MAO-A KO mice (Cases et al., 1995;
Scott et al., 2008). In these animals, MAO-A deﬁciency
leads to high levels of brain 5-HT and norepinephrine
(NE), as well as a spectrum of abnormal behavioural
responses, including high levels of inter-male
aggression (Cases et al., 1995; Scott et al., 2008;
Bortolato and Shih, 2011), social and communication
deﬁcits (Bortolato et al., 2012a), poor exploratory
behaviour towards novel contexts and objects (Godar
et al., 2011), reduced depression-like responses (Cases
et al., 1995), greater retention of aversive memories
(Kim et al., 1997; Dubrovina et al., 2006), reduced risk
assessment and maladaptive stress reactivity (Popova
et al., 2001; Godar et al., 2011), repeated and
perseverative responses as well as low learning reversal
(Bortolato et al., 2012a). While the neurobiological
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bases of the behavioural changes observed in MAO-A KO
mice are still incompletely understood, several ﬁndings
suggest that they may be underpinned by early
developmental mechanisms. In fact, chronic
pharmacological MAO-A inhibition in adult rodents does
not result in aggressiveness, but rather in decreased
defensive behaviour (Griebel et al., 1998), enhanced
exploratory activity (Steckler et al., 2001) and reduced
aggression (Isel et al., 1988). Conversely, treatment
with the MAO-A selective inhibitor clorgyline and other
MAO inhibitors induces behavioural alterations similar to
those documented in MAO-A KO mice (Whitaker-
Azmitia et al., 1994; Mejia et al., 2002). Recent studies
have also shown that the overt aggression exhibited by
MAO-A KO mice reﬂects alterations in the composition
and biophysical properties of NMDA glutamate
receptors of the prefrontal cortex (Bortolato et al.,
2012b). This ﬁnding is particularly interesting in
consideration of the key role of this region in the
emotional appraisal of social and environmental
contexts, as well as the well-documented function of
NMDA receptors in information processing.
In addition to the characterization of Brunner
syndrome, abundant clinical evidence on the role of
MAO-A in aggression has come from genetic studies of
the functional polymorphisms of MAOA gene and its
promoters. In particular, the MAOA-uVNTR, a 30-bp
VNTR polymorphism located 1.2 kb upstream of the
MAO-A coding sequence (Sabol et al., 1998), has been
associated with diﬀerent levels of transcriptional activity
of the MAOA gene. Of the six MAOA-uVNTR variants
characterized to date (with 2, 3, 3.5, 4 and 5 repeats)
(Huang et al., 2004a), the 3-repeat and 4-repeat (4R)
alleles have been respectively associated to lower and
higher transcriptional eﬃciency and catalytic activity
(Sabol et al., 1998; Deckert et al., 1999; Denney et al.,
1999).
In several studies, the 3R variant has been repeatedly
associated with antisocial personality, maladaptive
responsiveness to stress, deﬁcits in aﬀective processing
and lower cognitive functioning (Samochowiec et al.,
1999; Cohen et al., 2003; Contini et al., 2006; Oreland
et al., 2007; Brummett et al., 2008; Buckholtz and
Meyer-Lindenberg, 2008; Williams et al., 2009; but see
Koller et al., 2003 for contrasting results).
Notably, the link between genotypes and aggression
has been recently found to be dependent on a
gene  environment interaction, with male 3R-carriers
developing aggressive behaviour only when they had a
history of abuse and neglect during childhood (Caspi
et al., 2002; Foley et al., 2004; Huang et al., 2004b;
Kim-Cohen et al., 2006; Frazzetto et al., 2007; Weder
et al., 2009; Edwards et al., 2010).
Functional brain imaging studies have shown that, in
males, the 3R variant is associated with changes in the
volume of OFC, as well as hyperreactivity of the
amygdala and hippocampus during aversive recall
(Meyer-Lindenberg et al., 2006). These ﬁndings have
led Buckholtz and Meyer-Lindenberg (Buckholtz and
Meyer-Lindenberg, 2008) to theorize that the 3R
haplotype may interfere with the ontogenesis of the
prefrontal cortex and other regions of the corticolimbic
circuit, facilitating the emergence of negative socio-
cognitive bias. In support of this hypothesis,
Eisenberger et al. (2007) showed that low-activity
variants may enhance the sensitivity of negative social
experiences like social rejection. Thus, it is likely that
early traumatic experiences, in association with low-
activity MAO-A variants, may result in persistent
alterations of socio-emotional appraisal, which could
facilitate the insurgence of aggressive responses,
particularly in the presence of high-provocation
contingencies (McDermott et al., 2009) and threat-
related situations (Williams et al., 2009).
The association between MAOA-uVNTR variants and
MAO-A brain activity has been challenged by post-
mortem (Balciuniene et al., 2002) and PET studies
(Fowler et al., 2007); however, self-reported aggression
in men was found to be inversely correlated to the brain
activity of MAO-A irrespective of the genotype (Alia-
Klein et al., 2008). Collectively, these lines of evidence
suggest that polymorphic variants may confer higher or
lower ‘‘baseline’’ MAO-A activity levels during early life
stages (critical for the development of corticolimbic
circuitry); however, enzymatic function may be
subsequently altered by a broad set of environmental
elements throughout life (Bortolato and Shih, 2011).
The majority of association studies have failed to
detect a signiﬁcant correlation between MAOA-uVNTR
variants and suicidal behaviour (Kunugi et al., 1999;
Ono et al., 2002; De Luca et al., 2005a; De Luca et al.,
2006; De Luca et al., 2008a; Hung et al., 2012; but see
Lung et al., 2011 for contrasting evidence).
Nevertheless, one study has indicated that the
frequency of 2R and 3R alleles is signiﬁcantly higher in
men who had attempted suicide by violent means
compared to men who had committed suicide by non-
violent means (Courtet et al., 2005); this ﬁnding
suggests that the endophenotype associated with low
MAO-A activity may only aﬀect the modality of
execution, rather than the intention of suicidal actions.
Other functional polymorphisms, Fnu 4HI and Eco RV,
have also been investigated for the association with
aggression and suicide. Ho et al. (Ho et al., 2000)
reported an association of the FnuHI allele 1 – which is
responsible for the lower activity of MAO-A (Hotamisligil
and Breakeﬁeld, 1991) – with a history of suicide
attempts in female bipolar patients. Conversely, Du
et al. (2000)) found a signiﬁcant association between
high-activity related allele (allele 2) and suicide in
depressed male suicide victims. The signiﬁcance of
these ﬁndings awaits further studies to be clariﬁed.
CONCLUSIONS AND RESEARCH DIRECTIONS
The evidence overviewed in the previous sections, albeit
fraught with inconsistent results, is in support of a
pivotal role of 5-HT-ergic system (and its multiple
molecular components) in the pathophysiology of IABs
and other intermediate phenotypes underlying the
association between reactive aggression and suicide
(such as negative bias in the interpretation of
M. Bortolato et al. / Neuroscience 236 (2013) 160–185 173
ambiguous social cues, deﬁcits in social recognition etc.).
In particular, recent studies underscored that, while
alterations in 5-HT-ergic homoeostasis may signal
diﬀerent degrees of vulnerability to violent
aggressiveness and suicidal behaviours, their translation
into pathological conditions occurs only in the presence
of other critical environmental and gender-related
variables. The convergence of these factors is posited
to lead to enduring abnormalities of the socio-aﬀective
scaﬀolding (with respect to the connectivity between
prefrontal cortex, limbic areas and raphe´ nuclei), which
may ultimately result in higher proclivity to exhibit violent
outbursts and engage in self-harmful behaviours in
response to psychosocial stress or other contextual
triggers.
One of the most important limitations in human
studies, particularly in suicide completers, lies in the
intrinsic diﬃculty in recognizing the distinctive
contribution of diverse psychological characteristics (and
their neurochemical correlates) to multifaceted
behavioural phenomena such as aggression and
suicidality. The pursuit of this critical goal would enable
to distinguish ‘‘neurobiological signatures’’ relevant to
IABs from complex proﬁles of 5-HT-ergic dysfunctions
that may reﬂect the inﬂuence of comorbid disturbances,
such as depression or anxiety.
On the other hand, the translational value of most
animal studies on the neurobiological relationship
between aggression and suicidal conducts is greatly
limited by the lack of suicidal activity in animal models,
as well as the relatively poor characterization of the
diﬀerences between reactive and proactive elements of
aggression in experimental preparations. This premise
underscores the need for reﬁned ethological criteria to
recognize and distinguish diverse subtypes of
aggressive behaviours in animal models.
The acknowledgment of the critical importance of
gene  environment  gender interactions in aggression
promises to lead to the development of new, highly
isomorphic animal models of this disorder. Current
translational perspectives call for a greater interface
between these innovative experimental strategies and
genetic association studies with more reﬁned
assessment criteria. It is expected that the combination
of this perspective with complementary epigenetic,
transcriptomic, proteomic and brain-imaging approaches
will help develop a heuristic translational platform to
identify reliable biomarkers for the early diagnosis and
prevention of reactive aggression and suicidal
behaviours.
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